Pharming Group N.V.
PHARM.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €637,498 | €933,618 | €1,025,191 | €679,241 |
| - Cash | €53,037 | €61,741 | €207,342 | €191,725 |
| + Debt | €108,417 | €171,545 | €166,694 | €161,593 |
| Enterprise Value | €692,878 | €1,043,422 | €984,543 | €649,109 |
| Revenue | €286,887 | €245,316 | €205,622 | €189,853 |
| % Growth | 16.9% | 19.3% | 8.3% | – |
| Gross Profit | €231,821 | €220,104 | €188,060 | €169,670 |
| % Margin | 80.8% | 89.7% | 91.5% | 89.4% |
| EBITDA | €13,178 | €9,877 | €33,533 | €48,779 |
| % Margin | 4.6% | 4% | 16.3% | 25.7% |
| Net Income | -€10,644 | -€10,548 | €13,674 | €15,996 |
| % Margin | -3.7% | -4.3% | 6.7% | 8.4% |
| EPS Diluted | -0.015 | -0.013 | 0.015 | 0.018 |
| % Growth | -20.3% | -184.2% | -17.4% | – |
| Operating Cash Flow | -€1,733 | -€17,302 | €22,897 | €36,126 |
| Capital Expenditures | -€763 | -€1,464 | -€1,977 | -€15,958 |
| Free Cash Flow | -€2,495 | -€18,766 | €20,920 | €20,168 |